<p>Abbreviations:</p>−<p> = not applicable, BEL = Belgium, C = control group, GVHD = graft-versus-host disease, H = high dose, IC = intracoronary, IND = India, IRN = Iran, ITL = Italy, IV = peripheral intravenous, IM = intramyocardial, L = low dose, M = middle dose, SD = standard deviation, OV = omental vein, PRC = People's Republic of China, SPA = Spain, SWE = Sweden, T = treatment group, USA = United States of America,</p>+<p> = mean (range),</p>¥<p> = median (range),</p>#<p> = % male only provided for combined dose cohorts.</p>**<p>Control groups received lower doses of MSCs.</p
<p>Abbreviations: LOE = level of evidence; CVM = cardiovascular mortality; ADT = androgen depriva...
<p>A1: Immature dendritic cells (imDC) group. B1–3: Allopeptide-pulsed group. C1–4: Gene modificatio...
<p>Abbreviations: T, treated; C, control; HCC, hepatocellular carcinoma; NOS, Newcastle-Ottawa Scale...
<p>Abbreviations:</p><p>− = not applicable, ALS = amyotrophic lateral sclerosis, AUS = Australia, BE...
<p>Abbreviations:</p><p>− = not reported,</p>*<p> = range, C = control group, CV = central venous, I...
<p>Abbreviations: ref = reference; MC = multicenter; DB = double-blinded; vs = versus; RCT = randomi...
<p>Abbreviations:Ami = amifostine; IV = intravenous injection; IH = Subcutaneously injection; RT =...
<p>Abbreviations:</p><p>− = not reported,</p>+<p> = adverse event not defined a priori,</p>*<p> = cl...
<p>The denominator for each variable is the number of trials reporting such data. “Other Purpose” in...
<p><b>Abbreviations:</b> RCT, Randomized Controlled Trial; OAC, oral anticoagulation; UFH, Unfractio...
<p>Abbreviations: A, adriamycin; Bev, bevacizumab; C, cyclophosphomide; Cb, carboplatin; E, epirubic...
<p>Abbreviations:</p>+<p> = adverse event not defined a priori,</p>*<p> = clinical endpoint defined ...
<p>Abbreviations:</p>¥<p> = both follow-up duration and frequency defined a priori for adverse event...
<p><b>Abbreviation:</b> DB, double-blinded; RCT, randomised controlled trials; AR, airway responsive...
<p>Abbreviations: HC: healthy controls; HCV: treatment-naive patients with chronic hepatitis C; EVR:...
<p>Abbreviations: LOE = level of evidence; CVM = cardiovascular mortality; ADT = androgen depriva...
<p>A1: Immature dendritic cells (imDC) group. B1–3: Allopeptide-pulsed group. C1–4: Gene modificatio...
<p>Abbreviations: T, treated; C, control; HCC, hepatocellular carcinoma; NOS, Newcastle-Ottawa Scale...
<p>Abbreviations:</p><p>− = not applicable, ALS = amyotrophic lateral sclerosis, AUS = Australia, BE...
<p>Abbreviations:</p><p>− = not reported,</p>*<p> = range, C = control group, CV = central venous, I...
<p>Abbreviations: ref = reference; MC = multicenter; DB = double-blinded; vs = versus; RCT = randomi...
<p>Abbreviations:Ami = amifostine; IV = intravenous injection; IH = Subcutaneously injection; RT =...
<p>Abbreviations:</p><p>− = not reported,</p>+<p> = adverse event not defined a priori,</p>*<p> = cl...
<p>The denominator for each variable is the number of trials reporting such data. “Other Purpose” in...
<p><b>Abbreviations:</b> RCT, Randomized Controlled Trial; OAC, oral anticoagulation; UFH, Unfractio...
<p>Abbreviations: A, adriamycin; Bev, bevacizumab; C, cyclophosphomide; Cb, carboplatin; E, epirubic...
<p>Abbreviations:</p>+<p> = adverse event not defined a priori,</p>*<p> = clinical endpoint defined ...
<p>Abbreviations:</p>¥<p> = both follow-up duration and frequency defined a priori for adverse event...
<p><b>Abbreviation:</b> DB, double-blinded; RCT, randomised controlled trials; AR, airway responsive...
<p>Abbreviations: HC: healthy controls; HCV: treatment-naive patients with chronic hepatitis C; EVR:...
<p>Abbreviations: LOE = level of evidence; CVM = cardiovascular mortality; ADT = androgen depriva...
<p>A1: Immature dendritic cells (imDC) group. B1–3: Allopeptide-pulsed group. C1–4: Gene modificatio...
<p>Abbreviations: T, treated; C, control; HCC, hepatocellular carcinoma; NOS, Newcastle-Ottawa Scale...